August 24, 2015 - ASM Comments on the List of Select Agents and Toxins

The ASM submitted comments to the Centers for Disease Control and Prevention on the possession, use, and transfer of select agents and toxins.  The comments addressed adding certain Influenza virus strains to the List of Select Agents and Toxins.

August 17, 2015 - ASM Comments on NIH RFI on the Framework for the NIH-wide Strategic Plan

The ASM submitted comments to the National Institutes of Health (NIH) RFI on the Framework for the NIH-wide Strategic Plan.  The comments will help NIH develop a 5-year strategic plan to outline a vision for biomedical research that will pursue fundamental knowledge about the nature and behavior of living systems and apply that knowledge to extend healthy life and reduce illness and disability.

July 16, 2015 - Payment Determinations for Calendar Year 2016 for New Clinical Laboratory Tests

The ASM presented recommendations to the Centers for Medicare & Medicaid Services at its annual public meeting on payment levels for new tests to be included in the 2016 Clinical Laboratory Fee Schedule.


August 17, 2015 - ASM Comments on Department of State and Commerce Control Regulations for Certain Pathogens

The ASM submitted comments to the US Department of Commerce and the US State Department regarding the Category XIV materials (Toxicological Agents, Including Chemical Agents, Biological Agents, and Associated Equipment) included on the United States Munitions List and the Commerce Control List.

May 8, 2015 - ASM Comments on the 21st Century Cures Act

The ASM sent comments on the 21st Centurey Cures Initiative to the House Committee on Energy and Commerce.

TPL_asm2013_SEARCH